The c-Mesenchymal-epithelial transition factor (c-Met) is a distinct subfamily of receptor tyrosine kinases (RTKs) that is activated solely by hepatocyte growth factor (HGF) [1, 2], and plays a key role in tumor survival, growth, angiogenesis and Metastasis. Here, MET is linked to neoplasm.